Published in J Allergy Clin Immunol on November 01, 1986
Standardisation of spirometry. Eur Respir J (2005) 48.20
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
General considerations for lung function testing. Eur Respir J (2005) 7.99
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med (1998) 3.22
Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J (2007) 2.16
Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax (1998) 1.72
Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J (2005) 1.65
Revisited role for mucus hypersecretion in the pathogenesis of COPD. Eur Respir Rev (2010) 1.48
BAL neutrophilia in asthmatic patients. A by-product of eosinophil recruitment? Chest (1996) 1.46
Usefulness of peak expiratory flow measurements: is it just a matter of instrument accuracy? Thorax (2003) 1.45
Effect of methacholine challenge on cellular composition of sputum induction. Thorax (1999) 1.45
Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol (1985) (1990) 1.16
Beclomethasone/formoterol in the management of COPD: a randomised controlled trial. Respir Med (2010) 1.08
Regional expiratory flow limitation studied with Technegas in asthma. J Appl Physiol (1985) (2001) 1.07
Assessing the reversibility of airway obstruction. Chest (1998) 1.04
On the functional consequences of bronchial basement membrane thickening. J Appl Physiol (1985) (2001) 1.04
Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis (1991) 1.02
Differential role of CD80 and CD86 on alveolar macrophages in the presentation of allergen to T lymphocytes in asthma. Clin Exp Allergy (2001) 1.02
Effects of deep inhalation during early and late asthmatic reactions to allergen. Am Rev Respir Dis (1990) 1.01
Definition of COPD: based on evidence or opinion? Eur Respir J (2008) 1.01
Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha3beta1-integrin in tumour cells. Oncogene (2006) 1.00
Assessing the effect of deep inhalation on airway calibre: a novel approach to lung function in bronchial asthma and COPD. Eur Respir J (1998) 1.00
Respiratory dynamics during laughter. J Appl Physiol (1985) (2001) 0.97
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation. J Appl Physiol (1985) (1999) 0.96
Mechanisms for isolated volume response to a bronchodilator in patients with COPD. J Appl Physiol (1985) (2000) 0.94
Measurement of pulmonary resistance and dynamic compliance with airway obstruction. J Appl Physiol (1985) (1998) 0.93
Frequency of allergen-specific T lymphocytes in blood and bronchial response to allergen in asthma. J Allergy Clin Immunol (1993) 0.92
Expiratory flow limitation and regulation of end-expiratory lung volume during exercise. J Appl Physiol (1985) (1993) 0.91
Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma. Thorax (2000) 0.90
Self-change processes, self-efficacy and self-concept in relapse and maintenance of cessation of smoking. Psychol Rep (1982) 0.90
Effect of nedocromil sodium on adenosine- and methacholine-induced bronchospasm in asthma. Clin Allergy (1987) 0.90
On the causes of lung hyperinflation during bronchoconstriction. Eur Respir J (1997) 0.89
Maximal bronchoconstriction in humans. Relationship to deep inhalation and airway sensitivity. Am J Respir Crit Care Med (1996) 0.87
Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol (1985) (2001) 0.87
Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes. J Allergy Clin Immunol (1999) 0.87
Increase of asthma and allergic rhinitis prevalence in young Italian men. Int Arch Allergy Immunol (1996) 0.86
Expiratory airflow limitation and hyperinflation during methacholine-induced bronchoconstriction. J Appl Physiol (1985) (1993) 0.86
Sensitization to airborne allergens in children with respiratory symptoms. Ann Allergy Asthma Immunol (1996) 0.86
Effect of nedocromil sodium on the late asthmatic reaction to bronchial antigen challenge. J Allergy Clin Immunol (1989) 0.85
The repertoire of T-lymphocytes recovered by bronchoalveolar lavage from healthy nonsmokers. Eur Respir J (1996) 0.85
Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy (1996) 0.85
Oligoclonality of lung T lymphocytes following exposure to allergen in asthma. J Immunol (1995) 0.84
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy (2006) 0.84
Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J (1997) 0.84
Total and specific IgE in serum, bronchial lavage and bronchoalveolar lavage of asthmatic patients. Allergy (1983) 0.83
Effects of aerosol methacholine and histamine on airways and lung parenchyma in healthy humans. J Appl Physiol (1985) (1993) 0.83
Increased numbers of mast cells in bronchial mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis (1991) 0.83
Bronchoalveolar lavage and transbronchial lung biopsy in sarcoidosis and extrinsic allergic alveolitis. Eur J Respir Dis (1982) 0.83
Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. J Allergy Clin Immunol (1997) 0.83
Airway inflammation and occurrence of delayed bronchoconstriction in exercise-induced asthma. Am Rev Respir Dis (1992) 0.83
Time course and calcium dependence of sustained bronchoconstriction induced by deep inhalation in asthma. Am Rev Respir Dis (1991) 0.83
Antiinflammatory-antioxidant treatment with a methane sulfonanilide in allergen-induced asthma. Ann Allergy (1991) 0.82
Changes in residual volume during induced bronchoconstriction in healthy and asthmatic subjects. Am J Respir Crit Care Med (1994) 0.82
Two doses of oral ketamine, given with midazolam, for premedication in children. Minerva Anestesiol (2002) 0.82
Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax (2006) 0.82
Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol). Int J Clin Pharmacol Biopharm (1978) 0.82
Bronchial responsiveness is not increased by bronchoalveolar and bronchial lavage performed after allergen challenge. Am Rev Respir Dis (1991) 0.82
Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Am J Respir Crit Care Med (1999) 0.81
Extracellular cyclic ADP-ribose potentiates ACh-induced contraction in bovine tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol (2001) 0.81
Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report. Allergy (2007) 0.81
Lung elastic recoil during breathing at increased lung volume. J Appl Physiol (1985) (1999) 0.81
Relationship between quasi-static pulmonary hysteresis and maximal airway narrowing in humans. J Appl Physiol (1985) (1992) 0.81
Effects of lung volume and thoracic gas compression on maximal and partial flow-volume curves. Eur Respir J (1996) 0.81
Breathing during exercise in subjects with mild-to-moderate airflow obstruction: effects of physical training. J Appl Physiol (1985) (1999) 0.81
Frequency and specific sensitization to inhalant allergens within nuclear families of children with asthma and/or rhinitis. Ann Allergy Asthma Immunol (1997) 0.81
Airway eosinophilic inflammation and bronchial hyperresponsiveness after allergen inhalation challenge in asthma. Lung (1998) 0.80
Allergen challenge of passively sensitized human bronchi alters M2 and beta2 receptor function. Am J Respir Crit Care Med (1997) 0.80
Bronchial and bronchoalveolar inflammation in single early and dual responders after allergen inhalation challenge. Lung (1997) 0.80
The European Respiratory Journal makes COPD a priority. Eur Respir J (2011) 0.80
Selective differences in the expression of the homing receptors of helper lymphocyte subsets. Clin Immunol Immunopathol (1998) 0.79
[Coming together: the ATS/ERS consensus on clinical pulmonary function testing]. Rev Mal Respir (2007) 0.79
Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals. J Hosp Infect (2008) 0.79
In allergic asthma experimental exposure to allergens is associated with depletion of blood eosinophils overexpressing LFA-1. Allergy (2002) 0.79
Allergic inflammation and airway smooth muscle function. Sci Total Environ (2001) 0.79
Adenosine-induced bronchoconstriction: premedication with chlorpheniramine and nedocromil sodium. Eur J Respir Dis Suppl (1986) 0.79